市场调查报告书
商品编码
1401915
2030 年病患监测设备市场预测:按产品、最终用户和地区分類的全球分析Patient Monitoring Devices Market Forecasts to 2030 - Global Analysis By Product, By End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球病患监测设备市场规模为 469 亿美元,预计在预测期内将以 11.1% 的复合年增长率成长,到 2030 年达到 981 亿美元。
病患监测设备产业涉及用于监测和追踪病患生命征象、生理参数和整体健康状况的设备的开发、製造和分销。这些设备包含多种工具,从医院床边监视器到用于在临床环境之外进行持续监测的便携式或穿戴式装置。它经常测量心率、血压、体温和血氧饱和度等参数,让医疗保健专业人员能够即时评估患者的健康状况,便于早期疗育,并更好地进行诊断和治疗。让您可以监控状态。
据世界卫生组织 (WHO) 称,到 2020 年,慢性病将占所有死亡的约 73%,占全球疾病负担的 60%。此外,新兴经济体占这些疾病造成的死亡人数的 79%。
人们对穿戴式病患监测设备的兴趣日益浓厚
对穿戴式病患监测设备的日益偏好是病患监测设备市场的主要驱动因素。这些设备提供即时健康资料,并能够持续远端监测生命征象和健康参数。其非侵入性和便利性使患者成为医疗保健的积极参与者,并促进异常和慢性疾病的早期发现。小型化和增强连接等技术进步推动了市场成长,因为穿戴式监测设备为医疗保健专业人员提供全面的见解并改善诊断和预防护理。
特定监测设备的准确性和可靠性
儘管技术进步提高了监测能力,但一些设备的准确性和可靠性仍然令人担忧。读数的变化、校准问题和资料解释的不准确性可能会影响临床决策和患者照护。此外,某些类型设备的复杂性可能会导致操作错误和培训不足,从而进一步降低准确性。因此,这些设备的广泛采用和整合到日常临床实践中将受到阻碍,从而阻碍市场扩张。
慢性病增加
心血管疾病、糖尿病和呼吸系统疾病等慢性疾病需要持续监测,增加了对先进病患监测设备的需求。这些设备有助于远端健康监测、即时资料收集和及时干预,以加强患者护理和管理。随着慢性病人口的增加,对创新和非侵入性监测解决方案的需求不断增加,这推动了病患监测设备市场的扩张。
缺乏标准化和相容性
缺乏标准化和相容性对市场构成了重大威胁,因为它会阻碍设备和系统之间的无缝整合、资料共用和互通性。资料格式、通讯协定和设备介面的差异可能会阻碍不同监测设备和医疗IT系统之间的资讯交流。这种缺乏统一性通常会导致互通性挑战,使医疗保健提供者难以有效地汇总、分析和利用患者资料。此外,缺乏标准化协议限制了新技术和设备与现有医疗保健生态系统的集成,这可能导致碎片化和效率低下。所有这些因素都阻碍了市场的成长。
COVID-19 的爆发加速了对远距监护解决方案的需求,对病患监测设备市场产生了重大影响。随着医院变得拥挤且必须减少亲自就诊,远端患者监护设备的采用量激增。此外,人们越来越关注追踪 COVID-19 患者生命征象和氧气水平的先进监测系统,进一步刺激了这段时期此类设备的开发和部署。
预计在预测期内医院部门将是最大的
在预测期内,医院部门预计将是最大的。医院的优势源自于各部门监控设备的广泛且多样化的使用。该医院是急诊、重症患者护理、外科和专科护理的主要中心。由于许多患者需要持续监测,医院正在大力投资先进的监测系统,以提供跨医学专业的即时资料收集、快速干预、准确诊断和全面的患者照护,我们正在实现这一点。
预计血糖监测系统领域在预测期内复合年增长率最高
随着全球糖尿病盛行率的不断上升,对高效且用户友好的监测系统的需求增加,血糖监测系统领域预计将在病患监测设备市场显着成长。此外,连续血糖监测 (CGM) 和非侵入性监测解决方案等技术进步正在提高准确性和便利性,吸引更多用户。此外,不断提高的医疗保健意识和政府对糖尿病管理的倡议正在推动这些监测系统的采用,从而在该细分市场中呈现出巨大的成长潜力。
有几个因素导致北美在预测期内在病患监测设备市场占据主导地位。该地区拥有先进的医疗基础设施、高额医疗支出和创新医疗技术的高采用率。此外,有利的报销政策、庞大的患者群和积极的医疗管理方法也促进了市场的成长。此外,持续的技术进步和积极的研发努力正在巩固北美的地位。
在预测期内,由于人口快速增长、快速都市化和医疗保健支出不断增加,亚太地区将见证病患监测设备市场的最高增长。老年人口的不断增长以及这些慢性疾病的增加,加剧了对持续监测解决方案的需求。此外,扩大医疗基础设施、政府促进医疗保健可近性的措施以及创新技术的采用也促进了该地区的显着增长。
According to Stratistics MRC, the Global Patient Monitoring Devices Market is accounted for $46.9 billion in 2023 and is expected to reach $98.1 billion by 2030 growing at a CAGR of 11.1% during the forecast period. The patient monitoring devices industry is involved in the development, manufacturing, and distribution of devices used to monitor and track patients' vital signs, physiological parameters, and overall health status. These devices encompass a wide range of tools, from bedside monitors in hospitals to portable or wearable devices for continuous monitoring outside clinical settings. They often measure parameters like heart rate, blood pressure, temperature, oxygen saturation, and more, enabling healthcare professionals to assess patient health in real-time, facilitate early intervention, and monitor conditions for better diagnosis and treatment.
According to World Health Organization (WHO), chronic diseases account for around 73% of all deaths and 60% of the global burden of disease in 2020. Moreover, developing economies account for 79% of deaths attributed to these diseases.
Increasing inclination toward wearable patient monitoring devices
The growing preference for wearable patient monitoring devices serves as a key driver in the patient monitoring devices market. These devices offer real-time health data, enabling continuous and remote monitoring of vital signs and health parameters. Their non-intrusive nature and convenience empower patients to actively participate in their healthcare, promoting early detection of abnormalities and chronic conditions. With advancements in technology, including miniaturization and enhanced connectivity, wearable monitoring devices provide healthcare professionals with comprehensive insights, improving diagnosis and preventive care, thus driving market growth.
Accuracy and reliability of certain monitoring devices
While technological advancements have improved monitoring capabilities, concerns persist regarding the precision and reliability of some devices. Variations in readings, calibration issues, and inaccuracies in data interpretation can impact clinical decisions and patient care. Additionally, the complexity of certain devices may contribute to operator error or inadequate training, further compromising accuracy. Consequently, this inhibits broader adoption and integration of these devices into routine clinical practices, hindering the market expansion.
Increasing prevalence of chronic diseases
Chronic conditions like cardiovascular diseases, diabetes, and respiratory disorders demand continuous monitoring, fostering the need for advanced patient monitoring devices. These devices facilitate remote health monitoring, real-time data collection, and timely interventions, enhancing patient care and management. As the population affected by chronic illnesses rises, the demand for innovative, non-invasive monitoring solutions is growing, which is aiding in market expansion for patient monitoring devices.
Lack of standardization and compatibility
Due to its potential to hinder seamless integration, data sharing, and interoperability among devices and systems, a lack of standardization and compatibility poses a significant threat to the market. Variations in data formats, communication protocols, and device interfaces can impede the exchange of information between different monitoring devices and healthcare IT systems. This lack of uniformity often leads to interoperability challenges, making it difficult for healthcare providers to aggregate, analyze, and utilize patient data efficiently. Moreover, the absence of standardized protocols may limit the ability to incorporate new technologies and devices into existing healthcare ecosystems, leading to fragmentation and inefficiencies. All of these factors hinder market growth.
The COVID-19 pandemic significantly impacted the patient monitoring device market by accelerating the demand for remote monitoring solutions. With hospitals overwhelmed and the need to reduce in-person visits, remote patient monitoring devices experienced a surge in adoption. Additionally, there was a heightened focus on advanced monitoring systems to track vital signs and oxygen levels in COVID-19 patients, further spurring the development and deployment of such devices during this period.
The hospitals segment is expected to be the largest during the forecast period
Over the forecast period, the hospitals segment is expected to be the largest. The dominance of hospitals is attributed to their extensive and varied use of monitoring equipment across departments. Hospitals serve as primary centers for acute care, critical care, surgeries, and specialized treatments. With a high volume of patients requiring continuous monitoring, hospitals invest significantly in advanced monitoring systems to ensure real-time data collection, aiding in prompt interventions, precise diagnoses and comprehensive patient care across diverse medical specialties, which helps boost segment expansion.
The blood glucose monitoring systems segment is expected to have the highest CAGR during the forecast period
The blood glucose monitoring systems segment is poised for substantial growth in the patient monitoring device market due to the increasing prevalence of diabetes globally, which has amplified the demand for efficient and user-friendly monitoring systems. Additionally, technological advancements, such as continuous glucose monitoring (CGM) and non-invasive monitoring solutions have enhanced accuracy and convenience, attracting more users. Moreover, rising healthcare awareness, coupled with government initiatives for diabetes management, propels the adoption of these monitoring systems, indicating significant growth potential for this market segment.
During the forecast period, North America's dominance in the patient monitoring device market can be attributed to several factors. The region boasts advanced healthcare infrastructure, significant healthcare expenditure, and a high adoption rate of innovative medical technologies. Moreover, favorable reimbursement policies, a large patient pool, and a proactive approach toward healthcare management contribute to the market's growth. Additionally, continuous technological advancements and robust research & development initiatives further solidify North America's position.
During the forecast period, the Asia-Pacific region is set for the highest growth in the patient monitoring device market due to the region's burgeoning population, rapid urbanization, and increasing healthcare spending. Along with these rising chronic diseases, a growing geriatric population fuels the need for continuous monitoring solutions. Additionally, expanding healthcare infrastructure, government initiatives promoting healthcare access and the adoption of innovative technologies contribute to the region's significant growth.
Some of the key players in Patient Monitoring Devices Market include Abbott Laboratories, Boston Scientific Corporation, Draeger, Edwards Lifesciences Corporation, GE Healthcare, Infinium Medical, Masimo Corporation, Medtronic PLC, Mindray Medical International Limited, Natus Medical Incorporated, Nihon Kohden Corporation, Nonin Medical, Inc., Omron Healthcare, Philips Healthcare, Siemens Healthineers, Smiths Medical, Inc., Spacelabs Healthcare, Welch Allyn and ZOLL Medical Corporation.
In October 2023, Dozee introduces ambulatory connected patient monitoring system - 'Dozee Pro Ex' Equipped with an AI-powered early warning system that tracks the trends of vital parameters and provides timely alerts for possible clinical deterioration.
In August 2023, With FDA nod, GE HealthCare paints US launch of Portrait patient monitoring system. More than a year after unveiling its wearable, wireless patient monitoring system-with CE mark already in hand, allowing it to be used across Europe-GE HealthCare is bringing the Portrait Mobile technology across the pond. The system has secured FDA 510(k) clearance, the company announced Monday, allowing it to be used in hospitals in the U.S.
In April 2023, Honeywell has developed a real-time health monitoring system, which captures and records patients' vital signs both within the hospital setting and remotely.
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa Regions are also represented in the same manner as above.